Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Metabolic Associated Fatty Liver Disease (MAFLD) in Chinese Population Using ATI / SWE / SWD: a Prospective Multicenter Study

NCT04551716 is registered in ClinicalTrials.gov with Chinese PLA General Hospital as lead sponsor.

NCT NCT04551716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04551716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Metabolic Associated Fatty Liver Disease (MAFLD) in Chinese Population Using ATI / SWE / SWD: a Prospective Multicenter Study
Lead sponsor
Chinese PLA General Hospital
Phase
Observational
Overall status
Completed
Start date
September 10, 2020
Completion date
August 31, 2022
Enrollment
448 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic-dysfunction-associated fatty liver disease (mafld)